AEs (≥15%) for patients in part 2
| Preferred term . | All grades, n (%) . | Grade ≥3, n (%) . |
|---|---|---|
| CLL/SLL (n = 45) | ||
| Upper respiratory tract infection | 23 (51.1) | 0 |
| Neutropenia | 20 (44.4) | 14 (31.1) |
| Contusion | 15 (33.3) | 0 |
| Cough | 12 (26.7) | 0 |
| Diarrhea | 12 (26.7) | 0 |
| Fatigue | 12 (26.7) | 1 (2.2) |
| Pyrexia | 10 (22.2) | 0 |
| Petechiae | 8 (17.8) | 0 |
| Rash maculopapular | 8 (17.8) | 0 |
| Sinusitis | 8 (17.8) | 0 |
| Thrombocytopenia | 8 (17.8) | 3 (6.7) |
| Back pain | 7 (15.6) | 2 (4.4) |
| Dyspepsia | 7 (15.6) | 0 |
| Nausea | 7 (15.6) | 0 |
| Pneumonia | 7 (15.6) | 4 (8.9) |
| Rash | 7 (15.6) | 0 |
| R/R FL (n = 36) | ||
| Upper respiratory tract infection | 14 (38.9) | 0 |
| Contusion | 10 (27.8) | 0 |
| Fatigue | 9 (25.0) | 0 |
| Cough | 8 (22.2) | 0 |
| Nausea | 7 (19.4) | 0 |
| Rash | 7 (19.4) | 0 |
| Thrombocytopenia | 7 (19.4) | 2 (5.6) |
| Diarrhea | 6 (16.7) | 0 |
| Neutropenia | 6 (16.7) | 5 (13.9) |
| Petechiae | 6 (16.7) | 0 |
| Productive cough | 6 (16.7) | 0 |
| Preferred term . | All grades, n (%) . | Grade ≥3, n (%) . |
|---|---|---|
| CLL/SLL (n = 45) | ||
| Upper respiratory tract infection | 23 (51.1) | 0 |
| Neutropenia | 20 (44.4) | 14 (31.1) |
| Contusion | 15 (33.3) | 0 |
| Cough | 12 (26.7) | 0 |
| Diarrhea | 12 (26.7) | 0 |
| Fatigue | 12 (26.7) | 1 (2.2) |
| Pyrexia | 10 (22.2) | 0 |
| Petechiae | 8 (17.8) | 0 |
| Rash maculopapular | 8 (17.8) | 0 |
| Sinusitis | 8 (17.8) | 0 |
| Thrombocytopenia | 8 (17.8) | 3 (6.7) |
| Back pain | 7 (15.6) | 2 (4.4) |
| Dyspepsia | 7 (15.6) | 0 |
| Nausea | 7 (15.6) | 0 |
| Pneumonia | 7 (15.6) | 4 (8.9) |
| Rash | 7 (15.6) | 0 |
| R/R FL (n = 36) | ||
| Upper respiratory tract infection | 14 (38.9) | 0 |
| Contusion | 10 (27.8) | 0 |
| Fatigue | 9 (25.0) | 0 |
| Cough | 8 (22.2) | 0 |
| Nausea | 7 (19.4) | 0 |
| Rash | 7 (19.4) | 0 |
| Thrombocytopenia | 7 (19.4) | 2 (5.6) |
| Diarrhea | 6 (16.7) | 0 |
| Neutropenia | 6 (16.7) | 5 (13.9) |
| Petechiae | 6 (16.7) | 0 |
| Productive cough | 6 (16.7) | 0 |